Reviewer: WANG Qun, Literature Co-worker: ZHANG Jia-tao. Efficacy of The MAGE-A3 Immunotherapeutic as Adjuvant Therapy in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 226-229. DOI: 10.12019/j.issn.1671-5144.2018.04.009
|
Citation:
|
Reviewer: WANG Qun, Literature Co-worker: ZHANG Jia-tao. Efficacy of The MAGE-A3 Immunotherapeutic as Adjuvant Therapy in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 226-229. DOI: 10.12019/j.issn.1671-5144.2018.04.009
|
Reviewer: WANG Qun, Literature Co-worker: ZHANG Jia-tao. Efficacy of The MAGE-A3 Immunotherapeutic as Adjuvant Therapy in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 226-229. DOI: 10.12019/j.issn.1671-5144.2018.04.009
|
Citation:
|
Reviewer: WANG Qun, Literature Co-worker: ZHANG Jia-tao. Efficacy of The MAGE-A3 Immunotherapeutic as Adjuvant Therapy in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 226-229. DOI: 10.12019/j.issn.1671-5144.2018.04.009
|
DownLoad: